ScienceAsia ScienceAsia
ScienceAsia ScienceAsia
ScienceAsia
33 (2007)33 (2007)
33 (2007)33 (2007)
33 (2007)
205
observed in clinical data, an example of which is shown
in Figure 3 where a simulation of our model is shown
fitted with the experimental data, taking into account
the measurement errors. Solving (34) for A
1
gives us an
indication of the MAC (minimum antibiotic
concentration), while solving (35) for A
1
provides a
lower bound for the MIC (minimum inhibitory
concentration). According to Sharma et al
18
the amount
of time during which the antibacterial concentration
remains above the MIC or MAC is an important
determinant of deciding the dose regimens of an
antibacterial agent.
However, the “effective” antibiotic level A
1
for each
patient cannot be measured, but may by obtained by
interpolating the pharmaco-kinetic data collected from
controlled clinical trials. Considering equation (8), if
the antibiotic rate of change of A
is plotted against the
antibiotic level A at each moment in time, then the slope
of the fitted line that best fits the data shall give the value
of
ω
4
, and the y-intersect of the line gives the value of
A
1
ω
4
, thus yielding the effective antibiotic level A
1
characteristic to each patient. In this way, it is possible
to design the dosing regimen to obtain the desired
outcome in the control range given by (36).
Finally, in terms of maintenance of the community
stability in the GI tract, we can offer the following
interpretation. The transition from a stable situation of
Case 2 seen in Figure 5b to the unstable situation of
Case 1 seen in Figure 5a occurs with the realization of
condition (24). Considering this condition, we see that
it may be satisfied with low enough antibiotic level A
1
,
or sufficiently low removal rate of susceptible
population
ω
1
, or high enough carrying capacity
γ
of
the environment for the susceptible population, or
faster conversion of susceptible to resistant strain (low
K
γ
), or high enough initial nutrient level C
0
.
Also, transition from the stable situation of Case 3
seen in Figure 6c to that seen in Figure 5d again is
facilitated by the abundance of nutrients (large z
1
) or
efficient consumption of nutrients by the resistant
population (high
ψ
R
or low K
R
) so that z
1
>> z
4
even with
a high level of antimicrobial agents A
1
. Our model thus
bears support to the experimental observation of Freter
et al.
10
, already mentioned in the Introduction, that
suggested that competition for nutrients is of an
overriding importance in the activity that maintains the
stability of the microflora community. From such
analysis, we can suggest a possible control strategy that
combines appropriate drug protocol and strict diet
regimen.
CONCLUSION
We have discussed a model of bacteria responses
and resistance to antibiotics, which accounts for the
mechanisms involved in the bacteria-antibiotic
interactions in vivo. For a specific patient, it is possible
to determine the values of the parameters by
interpolating the data collected from controlled clinical
trials, as has been described above. The model can then
be used to simulate different dynamic behavior due to
different dosing regimes. Since routine application of
antibiotics inevitably leads to the emergence of drug
resistance, it is vital that strategies are divised to reduce
the speed with which this occurs.
Clinically, it is difficult to assess pharmaco-dynamic
effects of antibiotics due to the complexity in repeatedly
determining the bacterial load at the site of infection
and antibiotic concentrations during the dosing
interval
18
. Using dynamic models of bacteria-antibiotic
interactions can overcome these difficulties. Through
the model development and analysis, we gain an
understanding of the pharmaco-dynamic factors that
are involved in the process, while our model tries to
simulate human infection mechanisms and can suggest
how best the microbiological activity and antibacterial
pharmacokinetic data in vivo can be used to select an
antimicrobial agent and its dosage regimen that
minimizes GI tract overgrowth by resistant species.
The model might also be used to provide information
regarding the kinetics of elimination of resistant strains
once antimicrobial selection pressure has been relieved.
Such information could prove useful in designing,
monitoring, and control of empiric therapy stragies.
ACKNOWLEDGEMENTS
Appreciations are extended towards the Thailand
Research Fund and National Center for Genetic
Engineering and Biotechnology, National Science and
Technology Development Agency (contract no. 3-
2548) for financial support.
REFERENCES
1. Nolting and Derendorf H (1995) Pharmacokinetic/
Pharmacodynamic Modeling of Antibiotics. CRC Press.
2. Johnson SA, Nicolson SW and Jackson S (2004) The effect
of different oral antibiotics on the gastrointestinal microflora
of a wild rodent (Aethomys namaquensis). Comparative
Biochemistry and Physiology,
A138A138
A138A138
A138, pp 475-83.
3. Tannock GW (1999) Medical importance of the normal
microflora. Kluwer Academic Publ., Dordrecht, the
Netherlands,.
4. Van der Waaij D, Berghuis-deVries JM and Lekkerkerk-van
der Wees JEC (1972) Colonization resistance of the digestive
tract and the spread of bacteria to the lymphatic organs in
mice. J. Hyg.
70,70,
70,70,
70, pp 335-42.
5. Steffenand EK and Berg RD (1983) Relationship between
cecal population levels of indigenous bacteria and
translocation to the mesenteric lymph nodes. Infection and
Immunity
39(3)39(3)
39(3)39(3)
39(3), pp 1252-9.
6. Scott KP (2002) The role of conjugative transposons in